Opioid Industry Bankruptcies

Gilbert’s work to combat the opioid crisis includes significant involvement in the bankruptcy arena, including playing a major role in negotiating the 2021 bankruptcy settlement in In Re: Purdue Pharma LP that is currently on appeal in the Second Circuit. In 2020, Gilbert was similarly retained by the Ad Hoc Group of Governmental Entities Holding Opioid Claims in In re: Mallinckrodt PLC, the bankruptcy proceedings arising out of Mallinckrodt’s role in contributing to the opioid crisis.  Gilbert’s work in both bankruptcies builds on its decades of experience working on major corporate bankruptcies predicated by mass tort liabilities.

Gilbert is currently representing the Ad Hoc Committee of Governmental and Other Contingent Litigation claimants in an insurance coverage Adversary Proceeding in the Purdue Bankruptcy to secure funds to pay claimants once a plan of reorganization is ultimately completed.  Gilbert is also lead counsel in a coverage action filed on June 16, 2022 in Missouri state court on behalf of the Trust established to address opioid claims against Mallinckrodt.

The Purdue and Mallinckrodt bankruptcies are two of several opioid matters in which Gilbert is involved, including the MDL proceedings in Ohio and litigations by state attorneys general and sovereign Indian tribes against opioid manufacturers, distributors, chain retailers, and others seeking remediation and damages for the U.S. opioid crisis.